Pronova BioPharma Norge AS v. Teva Pharmaceuticals USA, Inc.

Petition for certiorari denied on October 6, 2014
Docket No. Op. Below Argument Opinion Vote Author Term
13-1251 Fed. Cir. N/A N/A N/A N/A OT 2014

Issue: Whether the statutory bar for “public use” of an invention under 35 U.S.C. § 102(b) (2006) (pre-America Invents Act) (current version at 35 U.S.C. § 102(a)(1)(2012)) broadly bars a patent when an innovator company allows any public access to its invention even if the invention is not actually used in public for its intended purpose.

SCOTUSblog Coverage

DateProceedings and Orders
Apr 16 2014Petition for a writ of certiorari filed. (Response due May 19, 2014)
May 15 2014Order extending time to file response to petition to and including June 18, 2014, for all respondents.
Jun 18 2014Brief of respondent Teva Pharmaceuticals USA, Inc., et al. in opposition filed.
Jul 2 2014DISTRIBUTED for Conference of September 29, 2014.
Oct 6 2014Petition DENIED.
 
Share:
Term Snapshot
Awards